US Patent 11084819 Polymorphs
Patent 11084819 was granted and assigned to Boehringer Ingelheim on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+169 characters)
Article
Patent abstract
The invention relates to polymorphous crystal modifications of a DPP-IV inhibitor, the preparation thereof and the use thereof for preparing a medicament.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110848190
Date of Patent
August 10, 2021
0Patent Application Number
201910240
Date Filed
October 24, 2019
0Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110848190
Date of Patent
August 10, 2021
0Patent Application Number
201910240
Date Filed
October 24, 2019
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11084819 Polymorphs
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11084819
Date of patent
August 10, 2021
Patent application number
20191024
Date Filed
October 24, 2019
Find more entities like US Patent 11084819 Polymorphs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
